News

The new patent application was filed for novel dosing combinations of RVX-208 and leading statin therapeutics based on the analysis of the Phase II study data. The study

Pre-clinical and clinical data generated to date indicate that isavuconazole has the potential to overcome many limitations of current therapies for the treatment of invasive fungal infections. Isavuconazole

EMD Serono‘s oral formulation of cladribine (Cladribine tablets) is an investigational treatment for patients with relapsing forms of multiple sclerosis (MS). Earlier, the FDA granted Priority Review status

The lawsuits were filed due to misbranding of Mokan and Micromox brands by the pharma firms violating Schedule P of the Drugs & Cosmetics Act. Pharmabiz quoted Ernakulam

Lab Dom claims that it had invented the first cellular therapy oral supplement product in the world, using hi-tech softgel capsules that can preserve the complete bioactivity of

Allergan said that Restasis is the first prescription eye drop to target the underlying cause of chronic Dry Eye. Allergan claimed that Restasis helps increase the eye’s natural

SICK said that the Lector 620 series offers real-time decoding of all images captured with a frequency of 60 Hz. Lector 620 can be used for counterfeit detection,

Blood lipids were monitored in two animal models in order to assess and compare the efficacy of CaPre and Lovaza over a 12-week treatment period. Acasti said that

The other two products Jean-Marie Pharmacal is also recalling are Elisa U tablet (HK-07463) and Triganet tablet (HK-28072). Samples of Delna-U Tablet collected during DH’s market surveillance were